- Home
- FSBC vs IMTX Comparison
FSBC vs IMTX Comparison
Compare FSBC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- IMTX
- Stock Information
- Founded
- FSBC 2002
- IMTX N/A
- Country
- FSBC United States
- IMTX Germany
- Employees
- FSBC N/A
- IMTX N/A
- Industry
- FSBC Banks
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSBC Finance
- IMTX Health Care
- Exchange
- FSBC Nasdaq
- IMTX Nasdaq
- Market Cap
- FSBC 628.9M
- IMTX 653.9M
- IPO Year
- FSBC 2021
- IMTX N/A
- Fundamental
- Price
- FSBC $31.22
- IMTX $5.63
- Analyst Decision
- FSBC Buy
- IMTX Strong Buy
- Analyst Count
- FSBC 5
- IMTX 4
- Target Price
- FSBC $34.80
- IMTX $14.67
- AVG Volume (30 Days)
- FSBC 33.8K
- IMTX 578.2K
- Earning Date
- FSBC 07-23-2025
- IMTX 08-13-2025
- Dividend Yield
- FSBC 2.55%
- IMTX N/A
- EPS Growth
- FSBC 2.40
- IMTX N/A
- EPS
- FSBC 2.44
- IMTX N/A
- Revenue
- FSBC $132,133,000.00
- IMTX $152,823,253.00
- Revenue This Year
- FSBC $33.14
- IMTX N/A
- Revenue Next Year
- FSBC $15.40
- IMTX $1.92
- P/E Ratio
- FSBC $12.88
- IMTX N/A
- Revenue Growth
- FSBC 18.01
- IMTX 83.61
- 52 Week Low
- FSBC $22.22
- IMTX $3.30
- 52 Week High
- FSBC $35.13
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- FSBC 57.43
- IMTX 39.53
- Support Level
- FSBC $29.48
- IMTX $5.42
- Resistance Level
- FSBC $31.63
- IMTX $5.67
- Average True Range (ATR)
- FSBC 1.06
- IMTX 0.35
- MACD
- FSBC 0.06
- IMTX -0.11
- Stochastic Oscillator
- FSBC 85.31
- IMTX 16.53
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.